Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable ...

Humira (adalimumab) is a prescription drug that’s used to treat certain types of arthritis and other inflammation-related diseases. It comes as a liquid solution for injection under your skin.

The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.

UCB announced positive results from the phase 3 active-controlled BE SURE study, which compared bimekizumab, an IL-17A and IL-17F inhibitor, to Humira (adalimumab) in adults with moderate-to ...

A new report released by the Michigan Health Purchasers Coalition suggests patients need to "shop around" to find the best ...

EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...